109 related articles for article (PubMed ID: 15821966)
21. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
[TBL] [Abstract][Full Text] [Related]
24. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for aromatic L-amino acid decarboxylase deficiency.
Hwu WL; Muramatsu S; Tseng SH; Tzen KY; Lee NC; Chien YH; Snyder RO; Byrne BJ; Tai CH; Wu RM
Sci Transl Med; 2012 May; 4(134):134ra61. PubMed ID: 22593174
[TBL] [Abstract][Full Text] [Related]
26. Seizure-Induced Increased 18F-DOPA Uptake in a Child With Diffuse Astrocytoma and Transient Brain MRI Abnormalities Related to Status Epilepticus.
Morana G; Bottoni G; Mancardi MM; Verrico A; Piccardo A
Clin Nucl Med; 2018 May; 43(5):e149-e150. PubMed ID: 29465492
[TBL] [Abstract][Full Text] [Related]
27. Visualization of the gall bladder on F-18 FDOPA PET imaging: a potential pitfall.
Balan KK
Clin Nucl Med; 2005 Jan; 30(1):23-4. PubMed ID: 15604962
[No Abstract] [Full Text] [Related]
28. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDOPA kinetics in brain tumors.
Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
[TBL] [Abstract][Full Text] [Related]
30. Effect of tetrabenazine on the striatal uptake of exogenous L-DOPA in vivo: a PET study in young and aged rhesus monkeys.
DeJesus OT; Shelton SE; Roberts AD; Nickles RJ; Holden JE
Synapse; 2002 Jun; 44(4):246-51. PubMed ID: 11984859
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy for aromatic L-amino acid decarboxylase deficiency.
Zwagerman NT; Richardson RM
Neurosurgery; 2012 Oct; 71(4):N10-2. PubMed ID: 22989964
[No Abstract] [Full Text] [Related]
32. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
33. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
[TBL] [Abstract][Full Text] [Related]
34. Microstructural changes of brain in patients with aromatic L-amino acid decarboxylase deficiency.
Lee WT; Lin JH; Weng WC; Peng SS
Hum Brain Mapp; 2017 Mar; 38(3):1532-1540. PubMed ID: 27859928
[TBL] [Abstract][Full Text] [Related]
35. [PET study using 6-[18F]-fluorodopa in Parkinson's disease].
Nagasawa H; Tanji H; Itoh M; Itoyama Y
Nihon Rinsho; 1997 Jan; 55(1):213-7. PubMed ID: 9014452
[TBL] [Abstract][Full Text] [Related]
36. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease.
Valles F; Fiandaca MS; Eberling JL; Starr PA; Larson PS; Christine CW; Forsayeth J; Richardson RM; Su X; Aminoff MJ; Bankiewicz KS
Neurosurgery; 2010 Nov; 67(5):1377-85. PubMed ID: 20871425
[TBL] [Abstract][Full Text] [Related]
37. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
[TBL] [Abstract][Full Text] [Related]
38. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
[TBL] [Abstract][Full Text] [Related]
39. Relation between brain tissue pO2 and dopamine synthesis of basal ganglia--a 18FDOPA-PET study in newborn piglets.
Bauer R; Brust P; Walter B; Vorwieger G; Bergmann R; Füchtner F; Steinbach J; el-Hallag E; Fritz A; Johannsen B; Zwiener U
J Perinat Med; 2000; 28(1):54-60. PubMed ID: 10765515
[TBL] [Abstract][Full Text] [Related]
40. Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies.
Fiumara A; Bräutigam C; Hyland K; Sharma R; Lagae L; Stoltenborg B; Hoffmann GF; Jaeken J; Wevers RA
Neuropediatrics; 2002 Aug; 33(4):203-8. PubMed ID: 12368991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
